IBDEI0FQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7574,2)
 ;;=^275514
 ;;^UTILITY(U,$J,358.3,7575,0)
 ;;=940.3^^49^558^17
 ;;^UTILITY(U,$J,358.3,7575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7575,1,3,0)
 ;;=3^Cornea/Conj,Acid Burn
 ;;^UTILITY(U,$J,358.3,7575,1,4,0)
 ;;=4^940.3
 ;;^UTILITY(U,$J,358.3,7575,2)
 ;;=^275515
 ;;^UTILITY(U,$J,358.3,7576,0)
 ;;=940.4^^49^558^19
 ;;^UTILITY(U,$J,358.3,7576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7576,1,3,0)
 ;;=3^Cornea/Conj,Oth Burn
 ;;^UTILITY(U,$J,358.3,7576,1,4,0)
 ;;=4^940.4
 ;;^UTILITY(U,$J,358.3,7576,2)
 ;;=^275516
 ;;^UTILITY(U,$J,358.3,7577,0)
 ;;=941.12^^49^558^31
 ;;^UTILITY(U,$J,358.3,7577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7577,1,3,0)
 ;;=3^Eye Erythema
 ;;^UTILITY(U,$J,358.3,7577,1,4,0)
 ;;=4^941.12
 ;;^UTILITY(U,$J,358.3,7577,2)
 ;;=^275531
 ;;^UTILITY(U,$J,358.3,7578,0)
 ;;=977.8^^49^558^4
 ;;^UTILITY(U,$J,358.3,7578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7578,1,3,0)
 ;;=3^Allergy to Fluorescein
 ;;^UTILITY(U,$J,358.3,7578,1,4,0)
 ;;=4^977.8
 ;;^UTILITY(U,$J,358.3,7578,2)
 ;;=^276154
 ;;^UTILITY(U,$J,358.3,7579,0)
 ;;=989.83^^49^558^111
 ;;^UTILITY(U,$J,358.3,7579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7579,1,3,0)
 ;;=3^Toxic Effect of Silicone
 ;;^UTILITY(U,$J,358.3,7579,1,4,0)
 ;;=4^989.83
 ;;^UTILITY(U,$J,358.3,7579,2)
 ;;=^303356
 ;;^UTILITY(U,$J,358.3,7580,0)
 ;;=995.29^^49^558^3
 ;;^UTILITY(U,$J,358.3,7580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7580,1,3,0)
 ;;=3^Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,7580,1,4,0)
 ;;=4^995.29
 ;;^UTILITY(U,$J,358.3,7580,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,7581,0)
 ;;=998.30^^49^558^25
 ;;^UTILITY(U,$J,358.3,7581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7581,1,3,0)
 ;;=3^Disruption OP Wound
 ;;^UTILITY(U,$J,358.3,7581,1,4,0)
 ;;=4^998.30
 ;;^UTILITY(U,$J,358.3,7581,2)
 ;;=^336767
 ;;^UTILITY(U,$J,358.3,7582,0)
 ;;=998.31^^49^558^27
 ;;^UTILITY(U,$J,358.3,7582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7582,1,3,0)
 ;;=3^Disruption of Internal OP Wound
 ;;^UTILITY(U,$J,358.3,7582,1,4,0)
 ;;=4^998.31
 ;;^UTILITY(U,$J,358.3,7582,2)
 ;;=^336843
 ;;^UTILITY(U,$J,358.3,7583,0)
 ;;=998.32^^49^558^26
 ;;^UTILITY(U,$J,358.3,7583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7583,1,3,0)
 ;;=3^Disruption of External OP Wound
 ;;^UTILITY(U,$J,358.3,7583,1,4,0)
 ;;=4^998.32
 ;;^UTILITY(U,$J,358.3,7583,2)
 ;;=^336844
 ;;^UTILITY(U,$J,358.3,7584,0)
 ;;=804.00^^49^558^37
 ;;^UTILITY(U,$J,358.3,7584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7584,1,3,0)
 ;;=3^FX Skull/Face Mult w/o Intracranial Inj
 ;;^UTILITY(U,$J,358.3,7584,1,4,0)
 ;;=4^804.00
 ;;^UTILITY(U,$J,358.3,7584,2)
 ;;=^273780
 ;;^UTILITY(U,$J,358.3,7585,0)
 ;;=V10.84^^49^558^47
 ;;^UTILITY(U,$J,358.3,7585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7585,1,3,0)
 ;;=3^Hx Eye CA,Personal
 ;;^UTILITY(U,$J,358.3,7585,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,7585,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,7586,0)
 ;;=V16.9^^49^558^46
 ;;^UTILITY(U,$J,358.3,7586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7586,1,3,0)
 ;;=3^Hx CA,Family
 ;;^UTILITY(U,$J,358.3,7586,1,4,0)
 ;;=4^V16.9
 ;;^UTILITY(U,$J,358.3,7586,2)
 ;;=^295301
 ;;^UTILITY(U,$J,358.3,7587,0)
 ;;=V19.0^^49^558^45
 ;;^UTILITY(U,$J,358.3,7587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7587,1,3,0)
 ;;=3^Hx Blindness/Visual Loss,Family
 ;;^UTILITY(U,$J,358.3,7587,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,7587,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,7588,0)
 ;;=V60.0^^49^558^55
 ;;^UTILITY(U,$J,358.3,7588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7588,1,3,0)
 ;;=3^Lack of Housing
